ANTICANCER COMPOSITIONS
The present invention concerns pharmaceutical formulations of abiraterone acetate and ARN-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (AR)-related disease or condition, in particular cancer, more in particular prostate cancer, including but...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
29.11.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!